Tab 4 · Pharmacological Care
Medical Treatment
An overview of medication management used alongside psychotherapy. Content is templated so it can be adapted to the chosen DSM-5 diagnosis.
Editable Placeholder
Most Commonly Prescribed Medications
- [Medication class — e.g., SSRIs, SNRIs, mood stabilizers, antipsychotics]
- [Example medication 1 — generic (brand)]
- [Example medication 2 — generic (brand)]
- [Example medication 3 — generic (brand)]
How the Medication Works
[Describe the mechanism of action — e.g., increases availability of serotonin in the synaptic cleft by blocking its reuptake into the presynaptic neuron, gradually improving mood regulation over 2–6 weeks.]
Neurotransmitters Involved
- [Primary neurotransmitter — e.g., serotonin]
- [Secondary neurotransmitter — e.g., norepinephrine]
- [Modulating systems — e.g., dopamine, GABA]
Typical Dosage Ranges
[Starting dose, target therapeutic range, and titration schedule. Always individualized by prescribing physician.]
Common Side Effects
- [Mild — e.g., nausea, headache, drowsiness]
- [Moderate — e.g., sleep disturbance, sexual side effects]
- [Rare but serious — discuss immediately with prescriber]
Monitoring Requirements
- Follow-up appointment every [interval]
- Symptom checklists at each visit
- [Bloodwork or vital sign monitoring if applicable]
- Suicide risk screening when clinically indicated
Neuroscience
Labeled Brain Diagram — Key Neurotransmitters
A simplified diagram illustrating major neurotransmitter systems commonly targeted by psychiatric medication.
Strengths
- Can reduce acute symptoms quickly, restoring daily functioning.
- Well-studied dosages and outcomes across diagnoses.
- Enables engagement in therapy by easing severe symptoms.
Limitations
- Possible side effects requiring careful monitoring.
- Does not address underlying thought patterns or life context on its own.
Integrated Care
Why Combining Medication and Therapy Is Effective
Improved symptom management: Medication can quickly reduce acute symptoms, allowing patients to fully engage in the cognitive and behavioral work of therapy.
Better long-term outcomes: Research (NIMH, APA) consistently shows that combined treatment outperforms either modality alone for moderate-to-severe depression and anxiety disorders.
Lower relapse rates: Therapy teaches durable coping skills that protect against recurrence after medication is tapered.
Increased patient functioning: Patients return to school, work, and relationships sooner — and often with greater insight than medication or therapy could deliver in isolation.